375 related articles for article (PubMed ID: 16357394)
1. Ferumoxtran-10-enhanced MR lymphangiography: does contrast-enhanced imaging alone suffice for accurate lymph node characterization?
Harisinghani MG; Saksena MA; Hahn PF; King B; Kim J; Torabi MT; Weissleder R
AJR Am J Roentgenol; 2006 Jan; 186(1):144-8. PubMed ID: 16357394
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of neck and body metastases to nodes with ferumoxtran 10-enhanced MR imaging: phase III safety and efficacy study.
Anzai Y; Piccoli CW; Outwater EK; Stanford W; Bluemke DA; Nurenberg P; Saini S; Maravilla KR; Feldman DE; Schmiedl UP; Brunberg JA; Francis IR; Harms SE; Som PM; Tempany CM;
Radiology; 2003 Sep; 228(3):777-88. PubMed ID: 12954896
[TBL] [Abstract][Full Text] [Related]
3. Urinary bladder cancer: preoperative nodal staging with ferumoxtran-10-enhanced MR imaging.
Deserno WM; Harisinghani MG; Taupitz M; Jager GJ; Witjes JA; Mulders PF; Hulsbergen van de Kaa CA; Kaufmann D; Barentsz JO
Radiology; 2004 Nov; 233(2):449-56. PubMed ID: 15375228
[TBL] [Abstract][Full Text] [Related]
4. Comparison of lymphotropic nanoparticle-enhanced MRI sequences in patients with various primary cancers.
Saksena M; Harisinghani M; Hahn P; Kim J; Saokar A; King B; Weissleder R
AJR Am J Roentgenol; 2006 Dec; 187(6):W582-8. PubMed ID: 17114509
[TBL] [Abstract][Full Text] [Related]
5. Preoperative diagnosis of lymph node metastases in gastric cancer by magnetic resonance imaging with ferumoxtran-10.
Tatsumi Y; Tanigawa N; Nishimura H; Nomura E; Mabuchi H; Matsuki M; Narabayashi I
Gastric Cancer; 2006; 9(2):120-8. PubMed ID: 16767368
[TBL] [Abstract][Full Text] [Related]
6. Preoperative esophageal cancer staging: magnetic resonance imaging of lymph node with ferumoxtran-10, an ultrasmall superparamagnetic iron oxide.
Nishimura H; Tanigawa N; Hiramatsu M; Tatsumi Y; Matsuki M; Narabayashi I
J Am Coll Surg; 2006 Apr; 202(4):604-11. PubMed ID: 16571430
[TBL] [Abstract][Full Text] [Related]
7. MR lymphangiography using ultrasmall superparamagnetic iron oxide in patients with primary abdominal and pelvic malignancies: radiographic-pathologic correlation.
Harisinghani MG; Saini S; Weissleder R; Hahn PF; Yantiss RK; Tempany C; Wood BJ; Mueller PR
AJR Am J Roentgenol; 1999 May; 172(5):1347-51. PubMed ID: 10227514
[TBL] [Abstract][Full Text] [Related]
8. Lymph node metastasis: ultrasmall superparamagnetic iron oxide-enhanced MR imaging versus PET/CT in a rabbit model.
Choi SH; Moon WK; Hong JH; Son KR; Cho N; Kwon BJ; Lee JJ; Chung JK; Min HS; Park SH
Radiology; 2007 Jan; 242(1):137-43. PubMed ID: 17090719
[TBL] [Abstract][Full Text] [Related]
9. Prostate cancer: detection of lymph node metastases outside the routine surgical area with ferumoxtran-10-enhanced MR imaging.
Heesakkers RA; Jager GJ; Hövels AM; de Hoop B; van den Bosch HC; Raat F; Witjes JA; Mulders PF; van der Kaa CH; Barentsz JO
Radiology; 2009 May; 251(2):408-14. PubMed ID: 19401573
[TBL] [Abstract][Full Text] [Related]
10. Axillary lymph node metastases in patients with breast carcinomas: assessment with nonenhanced versus uspio-enhanced MR imaging.
Memarsadeghi M; Riedl CC; Kaneider A; Galid A; Rudas M; Matzek W; Helbich TH
Radiology; 2006 Nov; 241(2):367-77. PubMed ID: 17057065
[TBL] [Abstract][Full Text] [Related]
11. MR lymphangiography: imaging strategies to optimize the imaging of lymph nodes with ferumoxtran-10.
Harisinghani MG; Dixon WT; Saksena MA; Brachtel E; Blezek DJ; Dhawale PJ; Torabi M; Hahn PF
Radiographics; 2004; 24(3):867-78. PubMed ID: 15143236
[TBL] [Abstract][Full Text] [Related]
12. [Use of SPIO-enhanced T1- and T2-weighted images for the differentiation of liver lesions: an ROC analysis].
Stroszczynski C; Gaffke G; Gretschel S; Rambow A; Jost D; Schlecht I; Schneider U; Schicke B; Hohenberger P; Gebauer B; Felix R
Rofo; 2003 Oct; 175(10):1368-75. PubMed ID: 14556106
[TBL] [Abstract][Full Text] [Related]
13. Superparamagnetic iron oxide-enhanced MR imaging of head and neck lymph nodes.
Mack MG; Balzer JO; Straub R; Eichler K; Vogl TJ
Radiology; 2002 Jan; 222(1):239-44. PubMed ID: 11756732
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic precision of nanoparticle-enhanced MRI for lymph-node metastases: a meta-analysis.
Will O; Purkayastha S; Chan C; Athanasiou T; Darzi AW; Gedroyc W; Tekkis PP
Lancet Oncol; 2006 Jan; 7(1):52-60. PubMed ID: 16389184
[TBL] [Abstract][Full Text] [Related]
15. Lymphotropic nanoparticle-enhanced MRI for independent prediction of lymph node malignancy: a logistic regression model.
Pandharipande PV; Mora JT; Uppot RN; Goehler A; Braschi M; Halpern EF; Gazelle GS; Harisinghani MG
AJR Am J Roentgenol; 2009 Sep; 193(3):W230-7. PubMed ID: 19696264
[TBL] [Abstract][Full Text] [Related]
16. Regional lymph node staging using lymphotropic nanoparticle enhanced magnetic resonance imaging with ferumoxtran-10 in patients with penile cancer.
Tabatabaei S; Harisinghani M; McDougal WS
J Urol; 2005 Sep; 174(3):923-7; discussion 927. PubMed ID: 16093989
[TBL] [Abstract][Full Text] [Related]
17. Pelvic lymph node topography for radiotherapy treatment planning from ferumoxtran-10 contrast-enhanced magnetic resonance imaging.
Dinniwell R; Chan P; Czarnota G; Haider MA; Jhaveri K; Jewett M; Fyles A; Jaffray D; Milosevic M
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):844-51. PubMed ID: 19095369
[TBL] [Abstract][Full Text] [Related]
18. MR imaging of mediastinal lymph nodes: evaluation using a superparamagnetic contrast agent.
Pannu HK; Wang KP; Borman TL; Bluemke DA
J Magn Reson Imaging; 2000 Dec; 12(6):899-904. PubMed ID: 11105028
[TBL] [Abstract][Full Text] [Related]
19. Urinary bladder cancer: preoperative nodal staging with ferumoxtran-10-enhanced MR imaging.
Montie JE
J Urol; 2005 Sep; 174(3):870-1. PubMed ID: 16093977
[No Abstract] [Full Text] [Related]
20. Lymphotropic nanoparticle enhanced MR imaging (LNMRI) technique for lymph node imaging.
Saksena MA; Saokar A; Harisinghani MG
Eur J Radiol; 2006 Jun; 58(3):367-74. PubMed ID: 16472955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]